Biotech
Moderna Finds That Inventing a Covid Vaccine Was the Easy Part
- Biotech beset by logistical problems in international markets
- Company lacks global factory networks like rival Pfizer
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know
Moderna Inc. has some of the highest-flying science in the biotech business. It brought its messenger RNA vaccine to the market in less than a year, faster than almost anyone thought possible.